The worldwide forecast for the safety needles market anticipates significant expansion, with a market value estimated at US$ 5,840.7 million in 2023. The projected CAGR of 7.4% from 2023 to 2033 suggests that the global safety needles market size is estimated to soar to a notable US$ 11,972.7 million by 2033.
Key Highlights
| Attributes | Details |
|---|---|
| Safety Needles Market Size (2023) | US$ 5,840.7 million |
| Safety Needles Market Projected Size (2033) | US$ 11,972.7 million |
| Forecasted Value CAGR (2023 to 2033) | 7.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Regulatory Emphasis on Needlestick Injury Prevention: Needlestick injuries are among the top causes of workplace injury in the healthcare industry. Several countries have utilized laws to encourage the application of safety-engineered needles. It is an essential approach to lowering the incidence of needlestick injuries among medical professionals. This has propelled the demand for safety needles. The focus on needlestick prevention techniques has been a driving force in the adoption of safety-engineered devices.
Heightened Awareness of Bloodborne Pathogens: Sharp injuries and other sharps-related injuries can expose employees to bloodborne infections. First responders, cleaning employees in various sectors, nurses, and other healthcare personnel are also in danger of being exposed to bloodborne diseases. However, nowadays, these healthcare professionals are becoming increasingly aware of bloodborne pathogens and the potential risks associated with needlestick injuries. This has spurred healthcare facilities to invest in safety needle technologies. This has led to a surge in sales of special purpose needles.
Rising Incidence of Chronic Diseases: Chronic diseases/non-communicable diseases Tobacco use, lack of physical activity, bad dietary habits, and overindulgence in alcohol are all key factors in the top chronic illnesses. Regardless of general wellness development, WHO stated that if current trends persist, chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory disorders are going to be responsible for 86% of the 90 million fatalities every year by 2050, representing an alarming 90% spike in overall mortality since 2019. This has led to an increased need for injections and vaccinations. Diabetic patients are fully reliant on regular insulin dosages for their well-being. Thus, customers in such categories are likely to have a strong desire for painless or pain-free needles to prevent the discomfort or disquiet of painful needles. This, in turn, is driving the demand for safety needles.
Technological Advancements in Needle Safety: Advanced medical technologies to lower the expenses of needle-stick infections are redesigning the way to needle safety. Re-sheathing systems are a highly prevalent type of safety feature. A needle cap and safety lock are examples of shielding that cover or rewind the needle after usage. The ETS needle's safety feature is simple to operate and requires no prior experience to utilize properly. This has played a pivotal role in the insulin pen needles market growth.
Evolving Patient Preferences and Empowerment: World leaders promised in 2015 to offer health care to all populations by 2030. The globe is simply halfway to completing the Sustainable Development Goals (SDGs) aim of obtaining complete health coverage by 2030 in 2023. Countries throughout the world are still feeling the effects of the epidemic after more than two and a half years. According to WHO, temporary boosts to government spending caused by the pandemic's aftermath amounted to a surge in global health expenditure close to US$9 trillion in 2020. This has facilitated greater access to advanced medical equipment, including safety needles. This expansion of healthcare facilities has expanded the needle market's reach.
Between 2017 and 2022, the safety needles market share reached from US$ 3,961.8 million to US$ 5,474.1 million, registering a 6.7% CAGR. The demand for safety needles increased due to growing awareness about healthcare-associated infections. Regulations and healthcare policies encouraged the use of safety needles. New safety features in needles caught the attention of healthcare providers and facilities, making them more interested in using them. This led to a gradual shift from conventional needles to safety needles.
| Safety Needles Market Size (2017) | US$ 3,961.8 million |
|---|---|
| Safety Needles Market Size (2022) | US$ 5,474.1 million |
| Historical Value CAGR (2017 to 2022) | 6.7% |
The safety needles market size is projected to reach from US$ 5,840.7 million in 2023 to US$ 11,972.7 million by 2033, exhibiting a 7.4% CAGR. The historical market growth lagged behind forecasts due to initial resistance to adopting safer medical practices. Healthcare facilities faced challenges in transitioning from traditional needles. Additionally, regulatory changes and production constraints contributed to the slower-than-anticipated growth during the historical period.
Looking ahead to 2023, the efforts made by the government to encourage people to get vaccinated are likely to boost the safety needle market growth down the line. This means that policies and programs aimed at promoting vaccinations are projected to play a significant role in making safety needles more widely used during the forecast period.
Prominent market players are focusing on the development of new products to meet the demands of safety needles in prenatal and postnatal research. Sharps Technology, Inc., a medical device and drug delivery organization that offers licensed, top-of-the syringe products, revealed the release of the company's concentrated pre-fillable syringe system lineup in January 2023. This needle is going to be developed through a partnership with Nephron Pharmaceuticals at the Inject EZ facility in the United States.
Principal Consultant
| Trends |
|
|---|---|
| Opportunities |
|
In 2022, North America secured its dominance in the global safety needles market with a 32.2% share, attributed to robust healthcare infrastructure and early adoption of advanced medical technologies. Europe closely trailed with 30.5%, driven by strong regulatory frameworks and a well-established healthcare system.
| Countries | 2022 Value Share in Global Market |
|---|---|
| United States | 27.8% |
| Germany | 7.9% |
| Japan | 8.5% |
The rising prevalence of chronic illnesses such as cancer, diabetes, and others is likely to fuel the steady expansion of the United States safety needles market during the forecast period. The United States emerged as the prime country in the North America safety pen needles market. Based on the American Cancer Society 2020 study, an estimated 1.8 million additional cases of cancer and 606,520 cancer-related fatalities were recorded in the United States in 2020. Furthermore, the overall incidence of chronic diseases such as Crohn's disease and diabetes, both of which can be managed with self-injectable medicine, is increasing. As per the Diabetes Research Institute Foundation, diabetes affects 10.5% of Americans, or 34.2 million individuals. Based on estimations, there were over 26.8 million people with diabetes in the country.
Needles are required for a multitude of diagnostic and therapeutic approaches for chronic illnesses, given their importance during drug and test management, boosting increasing calls for the product. Furthermore, safety needle market participants are using numerous methods to increase their market position, such partnerships and product launches. Smith's Medical, for example, partners with the United States government to produce a vaccine in January 2022. The collaboration with BARDA and JPEO-CBRND includes a US$ 20 million capital for increased syringe and needle device manufacturing to assist with the Operation Warp Speed vaccination program, which is projected to boost the market growth in the syringes & needles in the coming years.
Germany gearshifts the Europe safety needles market. Many people in Germany have chronic diseases across the country, such as HIV, diabetes, or multiple sclerosis. In a 2019 study conducted by the Forschungsgruppe Wahlen (an institution for election research in Germany), 46% of respondents said they had a chronic ailment. In all demographics, the percentage of individuals with conditions such as hypertension, lipid metabolism, diabetes, and coronary heart disease surpasses 20%.
Germany's healthcare system is built on four fundamental principles
In Germany, everyone is required to have insurance, which makes treatments more accessible for patients. Therefore, demand for adequate healthcare services and pharmaceuticals is increasing rapidly in the country. As a result of such initiatives, the retractable needle safety syringes market is likely to increase during the forecast period.
Cancer, heart disease, and cerebrovascular disease (CVD) are the three primary reasons for fatalities in Japan. A recent research in Japan found that more than 90% of persons aged 75 and over have a minimum of one chronic condition, with more than 80% having several chronic diseases. Furthermore, since 1981, cancer has remained the leading cause of mortality in Japan. The second worst cause of fatality is heart disease, which continues to be on the rise. It is evident that there is a critical need for safer medical procedures.
Safety needles offer a crucial advantage in this context, as they substantially reduce the risk of needlestick sharp injuries and potential transmission of infections. This heightened concern for patient safety is likely to drive healthcare providers and facilities to opt for safety needles over conventional ones. Globally, the country has a large presence in the production of medical equipment, including biopsy and anesthetic needles. With large production volumes, the country is poised to provide new development prospects for leading companies in the safety needles market.
| Countries | Value CAGR between 2023 and 2033 |
|---|---|
| United Kingdom | 7.0% |
| India | 11.1% |
| China | 9.7% |
The safety needles market in the United Kingdom is poised for significant growth in the coming years. In this country, the four primary persistent diseases for men and women were allergies, hypertension, low back problems, and depressive disorders. There is also a notable rise in the practice of self-administering medication within the comfort of one's home. The trend of self-administration has gained momentum as it offers individuals greater convenience and autonomy in managing their health conditions. Patients are increasingly opting to self-administer medications for various purposes, such as chronic disease management, vaccinations, and other medical treatments. The emphasis on safety and ease of use has become paramount, and safety needles aptly address these concerns.
India is expected to be the leading safety needles market in the Asia Pacific. Safety needles are becoming more popular in India as a result of the availability of low-cost raw materials, improved labor access, and an increase in the number of hospitals and healthcare institutions. India has witnessed a prominent medical tourism industry’s growth lately, particularly for orthopedic procedures. The country is becoming a popular location for safety needles. Factors such as rising government efforts to give vaccines to every newborn child, the substantial existence of needle producers, and awareness about contemporary trends in the aspiration & biopsy needles are boosting the safety needles market in India.
In 2019, around 17% of healthcare professionals in India engaged in dangerous injection practices. The percentage of dangerous injection procedures was greater among rural healthcare service providers, increasing the population's risk of injuries caused by needle sticks. Needle stick injuries (NSI) occurred in 52.2% of service providers, with an annual incidence of NSI of 19%. Furthermore, an increase in demand for vaccines and immunization, technical developments, and an increase in the usage of injectable medications are the significant drivers projected to drive the safety pen needle market growth during the projection period. In 2022, India sold US$ 496 billion in syringes with and without needles while obtaining US$ 957 billion in syringes with and without needles.
China is the second leading safety needles market, next to India. Based on the United States Institute for Health Metrics and Evaluation's global burden of disease report, strokes are the leading cause of death in China, closely followed by heart disease, chronic pulmonary disease, and lung cancer. China is putting a greater emphasis on improving the country's healthcare infrastructure. The emphasis on modernizing medical practices lines up perfectly with the integration of safety needles. This represents a significant leap forward in patient and healthcare worker safety.
The country has seen an important transition toward manufacturing low-cost needles for both domestic and foreign markets. China sold US$ 1.19 billion in Syringes, with or without needles, in 2021, thereby becoming the world's top supplier of Syringes, with or without needles. This is a key factor driving this country’s safety syringes market expansion. China-based manufacturers make use of economies of scale and superior production skills to provide competitive pricing without sacrificing quality. Furthermore, automation is increasingly being used in needle manufacturing processes, resulting in improved manufacturing effectiveness and overhead savings.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product type, the market is segmented into fine aspiring needles, biopsy needles, hypodermic needles, pen needles, suture needles, IV catheter needles, blood collection needles, spinal anesthesia and epidural needles, prefilled needles, A.V. fistula, cannula needles, and Huber needles. The hypodermic needles segment dominated the global market in 2022, accounting for a 17.2% share. In a similar vein, when considering the application, the safety needle market is divided into sample collection and drug delivery. Notably, the drug delivery segment took the lead, commanding an impressive 54.6% market share in 2022. Depending on the distribution channel, the market is categorized into hospitals pharmacies, private clinics, retail pharmacies & drug stores, and e-commerce. The hospitals pharmacies segment held the prime share at 50.9% in 2022.
| Segment | 2022 Value Share in Global Market |
|---|---|
| Hypodermic Needle | 17.2% |
| Drug Delivery | 54.6% |
| Hospital Pharmacies | 50.9% |
The demand for safety hypodermic needles is rising owing to their integrated safety features and invention in creating multi-safety needles. Since diabetic patients need to get periodic injections of insulin to be healthy, there is likely to be considerable demand for painless or pain-free needles to avoid any discomfort or disquiet connected with painful needles. As a result, the demand for safe hypodermic needles is rising at a steady rate, contributing to the overall safety needles market expansion. To preserve their market position, prominent companies in the hypodermic needles market are working on producing better needles. Terumo Corporation has created hypodermic syringes with built-in plunger stops that safeguard the needle from coming out.
The drug delivery sector is likely to have the upper hand in the safety needles market throughout the forecast period, owing to its utilization in expanding clinical applications. As the demand for various medications and vaccines continues to grow, the need for safe and efficient means of administering these substances becomes paramount. Moreover, the prevalence of chronic diseases, such as diabetes and various forms of cancer, has led to an increasing number of patients requiring regular injections or infusions. Safety needles offer a reliable method for healthcare professionals to administer drugs accurately while minimizing the risk of needlestick injuries.
The hospital pharmacies segment is estimated to lead the safety needles market throughout the forecast period. Given the availability of trained medical personnel and innovative technologies, target patients choose hospitals for treatment operations. The rising incidence of chronic diseases such as HIV, cancer, and spine disorders is prevalent. This rapidly growing number of chronic disease patients is also boosting hospital demand for vertebroplasty needles. These devices are utilized in the administration of drugs and the collecting of blood samples, both of which are primarily carried out by highly trained medical personnel in hospitals and operation centers. Hospitals are critical sites for several treatments, the bulk of which need the use of a needle in some form or another. As a result, hospital pharmacists ensure that their inventory is well stocked in order to provide the essential needle at the appropriate moment.
The global safety needles market exhibits a complex landscape characterized by many international and domestic companies, all vying for a significant stake in the market. This fragmentation underscores the diversity and competitiveness within the industry. Companies invest heavily in research and development to create cutting-edge safety needle technologies. They are also establishing strategic partnerships and collaborations with other organizations to access new markets. Many companies seek to expand their presence in different regions by entering new markets or acquiring established local businesses. Compliance with stringent regulatory requirements is overriding in the healthcare industry. Companies invest in ensuring that their products meet all safety and quality standards, which can differentiate them in the market.
Recent Developments in the Safety Needles Market
The global safety needles market is presently valued at US$ 5,840.7 million as of 2023.
The global safety needles market size is projected to surpass US$ 11,972.7 million by 2033, recording a 7.4% CAGR.
The key trend in the safety needles market is a growing demand for retractable and passive safety features to minimize needlestick injuries.
In 2022, the hypodermic needle market constituted a significant portion, holding a substantial 17.2% share within the broader safety needles market.
Countries with robust healthcare systems, like the United States, China, and India, are expected to drive significant demand for safety needles.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Fine Aspiring Needles 5.3.2. Biopsy Needles 5.3.3. Hypodermic Needles 5.3.4. Pen Needles 5.3.5. Suture Needles 5.3.6. IV Catheter Needles 5.3.7. Blood Collection Needles 5.3.8. Spinal Anesthesia and Epidural Needles 5.3.9. Prefilled Needles 5.3.10. A.V. Fistula 5.3.11. Cannula Needles 5.3.12. Huber Needles 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Sample Collection 6.3.2. Drug Delivery 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033 7.3.1. Hospitals Pharmacies 7.3.2. Private Clinics 7.3.3. Retail Pharmacies & Drug Stores 7.3.4. E-Commerce 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Application 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Application 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Application 14.2.4. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By Distribution Channel 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By Distribution Channel 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By Distribution Channel 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By Distribution Channel 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By Distribution Channel 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By Distribution Channel 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By Distribution Channel 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By Distribution Channel 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By Distribution Channel 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By Distribution Channel 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By Distribution Channel 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By Distribution Channel 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By Distribution Channel 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By Distribution Channel 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By Distribution Channel 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By Distribution Channel 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By Distribution Channel 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By Distribution Channel 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By Distribution Channel 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By Distribution Channel 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By Distribution Channel 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By Distribution Channel 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By Distribution Channel 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product 16.22.2.2. By Application 16.22.2.3. By Distribution Channel 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product 16.23.2.2. By Application 16.23.2.3. By Distribution Channel 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By Distribution Channel 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Medtronic Public Limited Company 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Boston Scientific Corp 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Becton Dickinson and Company 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Smith Medical 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Argon Medical Devices, Inc 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Novo Nordisk A/S 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Terumo Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. NIPRO Medical Corporation 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. B. Braun Melsungen AG 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Abbott Laboratories 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Eli Lilly and Company 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Safety Needles Market
